PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients

PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients

Abstract Objective Thrombolysis by recombinant tissue plasminogen activator (rt‐PA) is the main pharmacological therapy in acute ischemic stroke (IS); however, it is only effective in a subset of patients. Here we aimed to investigate the role of plasminogen activator inhibitor‐1 (PAI‐1), an effecti...

Full description

Bibliographic Details
Main Authors: István Szegedi, Attila Nagy, Edina G. Székely, Katalin R. Czuriga‐Kovács, Ferenc Sarkady, Levente I. Lánczi, Ervin Berényi, László Csiba, Zsuzsa Bagoly
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.50923

Similar Items

Similar Items